• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药用辅料对胃肠道代谢酶和转运体的影响——最新进展

The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update.

作者信息

Zhang Wenpeng, Li Yanyan, Zou Peng, Wu Man, Zhang Zhenqing, Zhang Tao

机构信息

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China.

School of Science and Humanities, Husson University, Bangor, Maine, USA.

出版信息

AAPS J. 2016 Jul;18(4):830-43. doi: 10.1208/s12248-016-9928-8. Epub 2016 May 16.

DOI:10.1208/s12248-016-9928-8
PMID:27184579
Abstract

Accumulating evidence from the last decade has shown that many pharmaceutical excipients are not pharmacologically inert but instead have effects on metabolic enzymes and/or drug transporters. Hence, the absorption, distribution, metabolism, and elimination (ADME) of active pharmaceutical ingredients (APIs) may be altered due to the modulation of their metabolism and transport by excipients. The impact of excipients is a potential concern for Biopharmaceutics Classification System (BCS)-based biowaivers, particularly as the BCS-based biowaivers have been extended to class 3 drugs in certain dosage forms. The presence of different excipients or varying amounts of excipients between formulations may result in bio-inequivalence. The excipient impact may lead to significant variations in clinical outcomes as well. The aim of this paper is to review the recent findings of excipient effects on gastrointestinal (GI) absorption, focusing on their interactions with the metabolic enzymes and transporters in the GI tract. A wide range of commonly used excipients such as binders, diluents, fillers, solvents, and surfactants are discussed here. We summarized the reported effects of those excipients on GI tract phase I and phase II enzymes, uptake and efflux transporters, and relevant clinical significance. This information can enhance our understanding of excipient influence on drug absorption and is useful in designing pharmacokinetic studies and evaluating the resultant data.

摘要

过去十年积累的证据表明,许多药物辅料并非无药理活性,而是会对代谢酶和/或药物转运体产生影响。因此,活性药物成分(API)的吸收、分布、代谢和排泄(ADME)可能会因辅料对其代谢和转运的调节作用而发生改变。辅料的影响是基于生物药剂学分类系统(BCS)的生物豁免的一个潜在问题,特别是因为基于BCS的生物豁免已扩展到某些剂型的3类药物。不同辅料的存在或不同制剂之间辅料用量的差异可能导致生物不等效。辅料的影响也可能导致临床结果出现显著差异。本文的目的是综述辅料对胃肠道(GI)吸收影响的最新研究结果,重点关注它们与胃肠道代谢酶和转运体的相互作用。本文讨论了多种常用辅料,如粘合剂、稀释剂、填充剂、溶剂和表面活性剂。我们总结了这些辅料对胃肠道I相和II相酶、摄取和外排转运体的报道影响以及相关临床意义。这些信息可以加深我们对辅料对药物吸收影响的理解,有助于设计药代动力学研究并评估所得数据。

相似文献

1
The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update.药用辅料对胃肠道代谢酶和转运体的影响——最新进展
AAPS J. 2016 Jul;18(4):830-43. doi: 10.1208/s12248-016-9928-8. Epub 2016 May 16.
2
Novel insights into excipient effects on the biopharmaceutics of APIs from different BCS classes: Lactose in solid oral dosage forms.从不同 BCS 分类的原料药的生物药剂学角度深入探讨赋形剂的影响:固体口服剂型中的乳糖。
Eur J Pharm Sci. 2014 Sep 30;61:27-31. doi: 10.1016/j.ejps.2014.03.008. Epub 2014 Apr 13.
3
Potential for pharmaceutical excipients to impact absorption: A mechanistic review for BCS Class 1 and 3 drugs.药用辅料对吸收的潜在影响:BCS 分类 1 和 3 药物的机制综述。
Eur J Pharm Biopharm. 2019 Aug;141:130-138. doi: 10.1016/j.ejpb.2019.05.020. Epub 2019 May 22.
4
Pharmaceutical Excipients and Drug Metabolism: A Mini-Review.药物辅料与药物代谢:小型综述
Int J Mol Sci. 2020 Nov 3;21(21):8224. doi: 10.3390/ijms21218224.
5
Using Physiologically Based Pharmacokinetic (PBPK) Modeling to Evaluate the Impact of Pharmaceutical Excipients on Oral Drug Absorption: Sensitivity Analyses.使用基于生理学的药代动力学(PBPK)模型评估药用辅料对口服药物吸收的影响:敏感性分析
AAPS J. 2016 Nov;18(6):1500-1511. doi: 10.1208/s12248-016-9964-4. Epub 2016 Aug 12.
6
Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir.常用辅料对生物药剂学分类系统3类药物西咪替丁和阿昔洛韦口服药物吸收的影响
J Pharm Sci. 2016 Feb;105(2):996-1005. doi: 10.1002/jps.24643. Epub 2016 Jan 12.
7
Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: impact on bioequivalence.影响生物利用度的活性药物成分与辅料之间的相互作用:对生物等效性的影响。
Eur J Pharm Sci. 2014 Dec 18;65:89-97. doi: 10.1016/j.ejps.2014.09.004. Epub 2014 Sep 16.
8
Pharmacokinetic simulations to explore dissolution criteria of BCS I and III biowaivers with and without MDR-1 efflux transporter.运用药代动力学模拟方法探索 MDR-1 外排转运体存在或不存在时 BCS I 和 III 生物豁免的溶出标准。
Eur J Pharm Sci. 2014 Sep 30;61:18-26. doi: 10.1016/j.ejps.2014.02.004. Epub 2014 Feb 22.
9
The effects of excipients on transporter mediated absorption.辅料对转运体介导吸收的影响。
Int J Pharm. 2010 Jun 30;393(1-2):17-31. doi: 10.1016/j.ijpharm.2010.04.019. Epub 2010 Apr 24.
10
The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.辅料对BCS III类化合物渗透性的影响及生物豁免的意义
Pharm Res. 2016 Jan;33(1):167-76. doi: 10.1007/s11095-015-1773-4. Epub 2015 Aug 19.

引用本文的文献

1
Comparative analysis of safety and efficacy between brand and generic lamotrigine products in the Saudi market.沙特市场上品牌拉莫三嗪产品与仿制药之间安全性和有效性的比较分析。
BMC Pharmacol Toxicol. 2025 Jul 1;26(1):125. doi: 10.1186/s40360-025-00963-7.
2
Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances.口服肽和蛋白质疗法给药的障碍与策略:临床进展最新情况
Pharmaceutics. 2025 Mar 21;17(4):397. doi: 10.3390/pharmaceutics17040397.
3
A Critical Overview of the Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption.

本文引用的文献

1
Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir.常用辅料对生物药剂学分类系统3类药物西咪替丁和阿昔洛韦口服药物吸收的影响
J Pharm Sci. 2016 Feb;105(2):996-1005. doi: 10.1002/jps.24643. Epub 2016 Jan 12.
2
Effects of Cremophor EL on the absorption of orally administered saquinavir and fexofenadine in healthy subjects.聚氧乙烯蓖麻油(Cremophor EL)对健康受试者口服沙奎那韦和非索非那定吸收的影响。
Drug Metab Pharmacokinet. 2015 Jun;30(3):221-6. doi: 10.1016/j.dmpk.2015.01.002. Epub 2015 Jan 29.
3
Inhibition of human efflux transporter ABCC2 (MRP2) by self-emulsifying drug delivery system: influences of concentration and combination of excipients.
辅料的生物学效应综述(上):对胃肠道吸收的影响。
AAPS J. 2022 May 2;24(3):60. doi: 10.1208/s12248-022-00711-3.
4
The pharmaceutical excipient PEG400 affect the absorption of baicalein in Caco-2 monolayer model by interacting with UDP-glucuronosyltransferases and efflux transport proteins.药用辅料聚乙二醇 400 通过与尿苷二磷酸葡萄糖醛酸转移酶和外排转运蛋白相互作用,影响 Caco-2 单层模型中黄芩素的吸收。
Pharmacol Res Perspect. 2022 Feb;10(1):e00928. doi: 10.1002/prp2.928.
5
Evaluation of Excipient Risk in BCS Class I and III Biowaivers.BCS 分类 I 和 III 生物豁免辅料风险评估。
AAPS J. 2022 Jan 5;24(1):20. doi: 10.1208/s12248-021-00670-1.
6
Assessing CYP2C8-Mediated Pharmaceutical Excipient-Drug Interaction Potential: A Case Study of Tween 80 and Cremophor EL-35.评估CYP2C8介导的药用辅料-药物相互作用潜力:吐温80和聚氧乙烯蓖麻油EL-35的案例研究
Pharmaceutics. 2021 Sep 17;13(9):1492. doi: 10.3390/pharmaceutics13091492.
7
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives.蛋白质和肽的口服递送:挑战、现状与未来展望。
Acta Pharm Sin B. 2021 Aug;11(8):2416-2448. doi: 10.1016/j.apsb.2021.04.001. Epub 2021 Apr 29.
8
Pharmaceutical Excipients and Drug Metabolism: A Mini-Review.药物辅料与药物代谢:小型综述
Int J Mol Sci. 2020 Nov 3;21(21):8224. doi: 10.3390/ijms21218224.
9
Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems.过饱和自乳化药物递送系统的现状
Pharmaceutics. 2020 Apr 16;12(4):365. doi: 10.3390/pharmaceutics12040365.
10
Size-Dependent Biological Effects of Quercetin Nanocrystals.槲皮素纳米晶体的尺寸依赖性生物效应。
Molecules. 2019 Apr 11;24(7):1438. doi: 10.3390/molecules24071438.
自乳化药物递送系统对人外排转运体ABCC2(多药耐药相关蛋白2)的抑制作用:辅料浓度及组合的影响
J Pharm Pharm Sci. 2014;17(4):447-60. doi: 10.18433/j3vp5h.
4
Commonly used excipients modulate UDP-glucuronosyltransferase 2b7 activity to improve nalbuphine oral bioavailability in humans.常用辅料可调节尿苷二磷酸葡萄糖醛酸转移酶2b7的活性,以提高纳布啡在人体中的口服生物利用度。
Pharm Res. 2014 Jul;31(7):1676-88. doi: 10.1007/s11095-013-1272-4. Epub 2014 Feb 14.
5
Inhibition mechanism of P-glycoprotein mediated efflux by mPEG-PLA and influence of PLA chain length on P-glycoprotein inhibition activity.甲氧基聚乙二醇-聚乳酸介导的P-糖蛋白外排抑制机制及聚乳酸链长度对P-糖蛋白抑制活性的影响
Mol Pharm. 2014 Jan 6;11(1):71-80. doi: 10.1021/mp4004223. Epub 2013 Nov 22.
6
Enhanced Permeability of Etoposide across Everted Sacs of Rat Small Intestine by Vitamin E-TPGS.维生素E-TPGS增强依托泊苷对大鼠小肠外翻囊的通透性
Iran J Pharm Res. 2013 Winter;12(Suppl):37-46.
7
Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibition.自微乳药物传递系统增强依托泊苷的肠道吸收:P-糖蛋白和细胞色素 P450 3A 抑制的作用。
Eur J Pharm Sci. 2013 Nov 20;50(3-4):429-39. doi: 10.1016/j.ejps.2013.08.016. Epub 2013 Aug 25.
8
Loss of orally administered drugs in GI tract.胃肠道中口服药物的损失。
Saudi Pharm J. 2012 Oct;20(4):331-44. doi: 10.1016/j.jsps.2012.03.005. Epub 2012 Apr 20.
9
Physiologically-Based Pharmacokinetic (PBPK) Modeling and Simulations Principles, Methods, and Applications in the Pharmaceutical Industry.基于生理的药代动力学(PBPK)建模与模拟:制药行业中的原理、方法及应用
CPT Pharmacometrics Syst Pharmacol. 2013 Jul 10;2(7):e55. doi: 10.1038/psp.2013.29.
10
Mediation of in vitro cytochrome p450 activity by common pharmaceutical excipients.常见药用辅料对体外细胞色素P450活性的介导作用。
Mol Pharm. 2013 Jul 1;10(7):2739-48. doi: 10.1021/mp400175n. Epub 2013 Jun 10.